Clinical trial
Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
NCT05724212 is registered in ClinicalTrials.gov with Paola Mantegani as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
- Lead sponsor
- Paola Mantegani
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 27, 2017
- Completion date
- February 1, 2025
- Enrollment
- 220 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.